Status:
COMPLETED
Effects of Lansoprazole on Bone Turnover Markers
Lead Sponsor:
Ataturk University
Conditions:
Bone Turnover Rate Disorder
Calcium Metabolism Disorders
Eligibility:
All Genders
16-18 years
Brief Summary
Use of proton pump inhibitors (PPI) has increased in recent years. There are concerns that PPIs have possible negative effects on bone metabolism. It has been suggested that PPIs may reduce the absorp...
Detailed Description
This study is planned to be conducted with children who are diagnosed with gastroesophageal reflux or gastroesophageal reflux disease aged 2-18 years and healthy volunteers. The diagnosis of gastroeso...
Eligibility Criteria
Inclusion
- • Patients diagnosed with gastroesophageal reflux or gastroesophageal reflux disease aged 16 to18 years.
Exclusion
- Patients with a malabsorptive disease.
- Patients with any chronic disease.
- Patients who use any medication that may affect calcium and bone metabolism.
- Patients who used proton pumps inhibitor within the last 3 months.
- Patients who do not use lansoprazole in the study group.
- Patients whose blood and urine samples are not taken in the eighth week of treatment.
Key Trial Info
Start Date :
December 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04814316
Start Date
December 2 2019
End Date
July 1 2021
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ataturk University Hospital
Erzurum, Turkey (Türkiye), 25240